New York State Common Retirement Fund boosted its stake in shares of Waters Corporation (NYSE:WAT) by 3.0% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 314,859 shares of the medical instruments supplier’s stock after buying an additional 9,100 shares during the period. New York State Common Retirement Fund owned approximately 0.40% of Waters worth $56,523,000 at the end of the most recent reporting period.
A number of other hedge funds also recently bought and sold shares of WAT. Janus Henderson Group PLC increased its holdings in shares of Waters by 20,670.6% in the 2nd quarter. Janus Henderson Group PLC now owns 1,929,793 shares of the medical instruments supplier’s stock worth $354,773,000 after purchasing an additional 1,920,502 shares in the last quarter. Koch Industries Inc. increased its holdings in shares of Waters by 36,932.0% in the 2nd quarter. Koch Industries Inc. now owns 534,742 shares of the medical instruments supplier’s stock worth $532,000 after purchasing an additional 533,298 shares in the last quarter. Fundsmith LLP increased its holdings in shares of Waters by 11.7% in the 2nd quarter. Fundsmith LLP now owns 3,833,955 shares of the medical instruments supplier’s stock worth $704,834,000 after purchasing an additional 401,420 shares in the last quarter. Renaissance Technologies LLC increased its holdings in shares of Waters by 214.5% in the 2nd quarter. Renaissance Technologies LLC now owns 526,400 shares of the medical instruments supplier’s stock worth $96,773,000 after purchasing an additional 359,000 shares in the last quarter. Finally, American Century Companies Inc. increased its holdings in shares of Waters by 200.4% in the 3rd quarter. American Century Companies Inc. now owns 512,899 shares of the medical instruments supplier’s stock worth $92,076,000 after purchasing an additional 342,134 shares in the last quarter. 92.29% of the stock is owned by institutional investors.
WAT has been the subject of a number of research analyst reports. Deutsche Bank lifted their target price on Waters from $199.00 to $200.00 and gave the stock a “hold” rating in a report on Wednesday, October 25th. Zacks Investment Research raised Waters from a “hold” rating to a “buy” rating and set a $211.00 target price for the company in a report on Monday, October 23rd. Barclays lifted their target price on Waters from $188.00 to $193.00 and gave the stock an “equal weight” rating in a report on Wednesday, October 25th. Bank of America lifted their target price on Waters from $192.00 to $202.00 and gave the stock a “neutral” rating in a report on Friday, November 10th. Finally, Cowen reissued a “hold” rating and issued a $190.00 target price on shares of Waters in a report on Friday, November 3rd. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating, five have issued a buy rating and one has given a strong buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $193.62.
Shares of Waters Corporation (NYSE WAT) traded down $0.41 on Wednesday, hitting $194.26. The company had a trading volume of 307,900 shares, compared to its average volume of 515,291. The company has a quick ratio of 5.71, a current ratio of 6.16 and a debt-to-equity ratio of 0.66. Waters Corporation has a one year low of $133.71 and a one year high of $201.95. The company has a market capitalization of $15,482.69, a price-to-earnings ratio of 27.04, a P/E/G ratio of 2.82 and a beta of 0.82.
Waters (NYSE:WAT) last issued its quarterly earnings data on Tuesday, October 24th. The medical instruments supplier reported $1.77 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.74 by $0.03. Waters had a return on equity of 23.61% and a net margin of 24.34%. The company had revenue of $565.58 million during the quarter, compared to analyst estimates of $555.25 million. During the same quarter in the previous year, the company posted $1.57 earnings per share. Waters’s revenue was up 7.4% compared to the same quarter last year. research analysts anticipate that Waters Corporation will post 7.42 earnings per share for the current fiscal year.
In related news, Director Thomas P. Salice sold 3,500 shares of Waters stock in a transaction on Monday, November 20th. The stock was sold at an average price of $200.03, for a total value of $700,105.00. Following the completion of the sale, the director now owns 20,349 shares of the company’s stock, valued at $4,070,410.47. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Rohit Khanna sold 18,400 shares of Waters stock in a transaction on Friday, September 8th. The shares were sold at an average price of $185.78, for a total value of $3,418,352.00. Following the transaction, the senior vice president now owns 22,477 shares in the company, valued at $4,175,777.06. The disclosure for this sale can be found here. Insiders sold 64,313 shares of company stock valued at $12,503,037 in the last ninety days. 5.07% of the stock is currently owned by corporate insiders.
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
Receive News & Ratings for Waters Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Corporation and related companies with MarketBeat.com's FREE daily email newsletter.